In Depth 3 Jul 2025 Revolutionizing glioblastoma treatment: How CAR-T cell therapy could represent a cure for this deadly brain cancer Find out how CAR-T cell therapy, which has been so groundbreaking in treating blood cancers, could potentially cure glioblastoma. July 3, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 28 May 2025 Myasthenia gravis treatments: what’s on the horizon? Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis. May 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 21 May 2025 Layoffs in the US: what is going on with genomics companies? Genomics companies have been slashing jobs and culling programs in the US. Learn about the layoffs that have struck the industry in 2025. May 21, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 16 Apr 2025 Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy. April 16, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 4 Feb 2025 World Cancer Day: trends in cancer therapeutics to look forward to in 2025 As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025. February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jan 2025 The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region. January 10, 2025 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Dec 2024 Six biotech companies leading the way in India Discover six of the top biotech companies in India, which is currently brimming with biotechs and a young, skilled workforce. December 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 27 Dec 2024[Rebroadcast] The power of natural killer cells December 27, 2024 Share WhatsApp Twitter Linkedin Email Listen Now More
In Depth 9 Dec 2024 CAR-T cell therapy for lupus: An emerging field with great potential Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune disorder. December 9, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024 Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies? Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies. October 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 14 Aug 2024 CAR-T drugs and parkinsonism: a cause for concern? CAR-T therapies come with boxed warnings of serious neurotoxic side effects. Now, growing concerns over parkinsonism have led to a clinical trial halt. August 14, 2024 - 3 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Lumicks 14 May 2024 Cell avidity-tuning ensures safe CAR-T therapy for solid tumors Learn more about the potential of cell avidity in designing potent and safe CAR-T treatments for solid tumors. May 14, 2024 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email